Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?
Cheng‐Lung Ku, Francesco Bianchi-Demicheli, Horst von Bernuth, et al.
Human Genetics (2020) Vol. 139, Iss. 6-7, pp. 783-794
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Mycobacterial diseases in patients with inborn errors of immunity
Stéphanie Boisson‐Dupuis, Jacinta Bustamante
Current Opinion in Immunology (2021) Vol. 72, pp. 262-271
Open Access | Times Cited: 37
Autoantibodies - enemies, and/or potential allies?
Hui Ma, Caroline Murphy, Christine E. Loscher, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Autoantibodies to Interferons in Infectious Diseases
Eugenia Quirós-Roldán, Alessandra Sottini, Simona Signorini, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1215-1215
Open Access | Times Cited: 15
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T
Tanya B. Dorff, Yosuke Hirasawa, Jared D. Acoba, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002931-e002931
Open Access | Times Cited: 28
Reconciling Mouse and Human Immunology at the Altar of Genetics
Philippe Gros, Jean‐Laurent Casanova
Annual Review of Immunology (2022) Vol. 41, Iss. 1, pp. 39-71
Open Access | Times Cited: 22
Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis
Hélène Salvator, Aristine Cheng, Lindsey B. Rosen, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children
Giorgia Bucciol, Isabelle Meyts, Laurent Abel, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 4, pp. 832-840
Open Access | Times Cited: 11
Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity
Aristine Cheng, Steven M. Holland
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 1, pp. 24-28
Open Access | Times Cited: 18
Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
Aurélie Cobat, Qian Zhang, Laurent Abel, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 465-486
Open Access | Times Cited: 10
Insights from a Case of Good’s Syndrome (Immunodeficiency with Thymoma)
Roberto Paganelli, Michela Di Lizia, Marika D’Urbano, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1605-1605
Open Access | Times Cited: 10
Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients
Arnau Antolí, José Pablo Gómez-Vázquez, Àngels Sierra-Fortuny, et al.
Clinical Immunology (2025) Vol. 276, pp. 110491-110491
Closed Access
Anti-cytokine autoantibodies in human susceptibility to infectious diseases: insights from Inborn errors of immunity
Kosuke Noma, Takaki Asano, Maki Taniguchi, et al.
Immunological Medicine (2025), pp. 1-17
Open Access
Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options
Gabriela Barcenas‐Morales, Paulina Cortes-Acevedo, Rainer Döffinger
Current Opinion in Infectious Diseases (2019) Vol. 32, Iss. 4, pp. 330-336
Open Access | Times Cited: 26
Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response
Han-Po Shih, Jing-Ya Ding, Junel Sotolongo Bellón, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 9
Open Access | Times Cited: 16
Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia
Paul Bastard, Qian Zhang, Aurélie Cobat, et al.
Comptes Rendus Biologies (2021) Vol. 344, Iss. 1, pp. 19-25
Open Access | Times Cited: 20
SERPINA1, generalized pustular psoriasis, and adult‐onset immunodeficiency
Piranit Nik Kantaputra, Suteeraporn Chaowattanapanit, Salin Kiratikanon, et al.
The Journal of Dermatology (2021) Vol. 48, Iss. 10, pp. 1597-1601
Closed Access | Times Cited: 20
Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte–Macrophage Colony-Stimulating Factor
Shang‐Yu Wang, Yu-Fang Lo, Han-Po Shih, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 8, pp. 1730-1741
Closed Access | Times Cited: 14
Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 8
Clinicopathological Manifestations and Immune Phenotypes in Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibodies
Yi‐Chun Chen, Shao‐Wen Weng, Jing-Ya Ding, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 672-683
Open Access | Times Cited: 12
Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives
Srijan Chatterjee, Manojit Bhattacharya, Sanskriti Saxena, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 5
Closed Access | Times Cited: 2
Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals
Paul Gray, Adam Bartlett, Stuart G. Tangye
Clinical & Translational Immunology (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
Henriette Didriksen, Øyvind Molberg, Adi Mehta, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19
Cheng‐Lung Ku, I‐Ting Chen, Ming‐Zong Lai
FEBS Journal (2021) Vol. 288, Iss. 17, pp. 5021-5041
Open Access | Times Cited: 14
Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections
Zhaoming Chen, Xiao-Yun Yang, Zhengtu Li, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 3381-3393
Open Access | Times Cited: 9
Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?
Quentin Philippot, Jean‐Laurent Casanova, Anne Puel
Current Opinion in Immunology (2021) Vol. 72, pp. 318-323
Open Access | Times Cited: 12

Scroll to top